<DOC>
	<DOC>NCT00145457</DOC>
	<brief_summary>To assess the predictive value of the short term IGF-1 stimulation test, based on IGF-1 changes, on the 24 months growth response to 2 different doses of GH in patients with conventional GH deficiency.</brief_summary>
	<brief_title>IGF1 Generation Test</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<criteria>Male or female aged of more than 4 years. GHD defined as a peak GH level &lt; 20 mUI/ml at two different pharmacological GH provocative tests including one done with two pharmacological agents and both performed within the year before the inclusion, according to the current recommendations of the French Health Authorities Previous treatment with GH Ongoing pharmacological treatment with steroids except if corresponding to substitutive therapy</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>